Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.
Also called NCT05225935
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 119 participants
- Registry
-
NCT05225935
-
- Other papers using this trial's data
- Computed tomography-guided vs conventional catheter ablation for ventricular tachycardia: the InEurHeart trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, France, Germany, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT05225935. Randomized; single masking; primary purpose treatment. Start 2022-06-29 (actual); primary completion 2023-12-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia
- Acronym
- InEurHeart
- Condition
- Ventricular Tachycardia
- Intervention (Device)
- image-guided VT ablation strategy
- Intervention (Device)
- conventional VT ablation strategy
- Lead sponsor
- University Hospital, Bordeaux
- Collaborator
- EIT Health
Record details
- Record id
cardio:ct-nct05225935- Content hash
3ae920c743c719f3412aacfd19d3586c31809c2d1d9ca742cf55c91d8981ce77